Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Mark P. Chao, Ash A. Alizadeh, Chad Tang, +17

Cell

Lymphoid NeoplasiaCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorEradicate Non-hodgkin Lymphoma +4

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

Eva Bandrés, Elena Cubedo, Xabier Agirre, +8

Molecular Cancer

Differentiation stage–specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas

Raquel Malumbres, Kristopher A. Sarosiek, Elena Cubedo, +5

Blood

MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP

Alvaro J. Alencar, Raquel Malumbres, Goldi A. Kozloski, +9

Clinical Cancer Research

PTP1B is a negative regulator of interleukin 4–induced STAT6 signaling

Xiaoqing Lu, Raquel Malumbres, Benjamin Shields, +5

Blood

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP

Raquel Malumbres, Jun Chen, Rob Tibshirani, +10

Blood

Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas

Kristopher A. Sarosiek, Raquel Malumbres, Hovav Nechushtan, +3

Blood

Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells

Beatriz Aldaz, Ainara Sagardoy, Lorena Nogueira, +10

PLoS ONE

Neuro-oncologyTumor SubpopulationDevelopmental BiologyGliomaGlioblastoma Multiforme +12

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer

Anna Martínez‐Cardús, Eva Martinez‐Balibrea, Eva Bandrés, +6

Molecular Cancer Therapeutics

EngineeringChemoprevention StrategyPharmacogenomic ApproachPathologyOxaliplatin Resistance Acquisition +20

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

Elena Beltrán, Vicente Fresquet, Javier Martínez‐Useros, +15

Proceedings of the National Academy of Sciences